Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill

INTRODUCTION: Hyperlactatemia is frequent in critically ill patients and is often used as a marker of adverse outcome. However, studies to date have focused on selected intensive care unit (ICU) populations. We sought to determine the occurrence and relation of hyperlactatemia with ICU mortality in...

Descripción completa

Detalles Bibliográficos
Autores principales: Khosravani, Houman, Shahpori, Reza, Stelfox, H Thomas, Kirkpatrick, Andrew W, Laupland, Kevin B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717461/
https://www.ncbi.nlm.nih.gov/pubmed/19523194
http://dx.doi.org/10.1186/cc7918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717461/
https://www.ncbi.nlm.nih.gov/pubmed/19523194
http://dx.doi.org/10.1186/cc7918

Ejemplares similares